This looks like a great report, read the part below:
Dr. Joseph Librizzi, President and Chief Executive Officer, said, ''We are pleased with the strong growth in the Company's
revenue and earnings this quarter. While much of this growth came from our medical products division where we had a 248%
increase in revenue, we also experienced significant increases in our core scientific and industrial products division, where
revenues were 20% ahead of last year. Approximately half of the medical products growth came from our exclusive agreement
with United States Surgical Corporation (NYSE: USS - news), as shipments to USS began in November 1997.''
Dr. Librizzi added, ''Our relationship with U.S. Surgical is ahead of plan, having reached several milestones relating to our
exclusive license agreement. During the quarter we began shipments of ultrasonic generators and transducers, which are the
main components of USS's AutoSonix(a) ultrasonic cutting system. We also received an initial order for the manufacture of
probes to be used with AutoSonix(a), as well as a follow-up order for ultrasonic generators and transducers.''
Looks like MSON is firing on all cylinders.........;^) |
